MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2.

作者: Dongyi Zhu , Li Gu , Zhanxia Li , Wenjing Jin , Qingchun Lu

DOI: 10.1016/J.PRP.2019.01.029

关键词:

摘要: Abstract Background MiR-138-5p is regarded as a tumour suppressor in many cancers. Transforming growth factor beta (TGF-β) often acts tumor promotor at the late stages of human However, function miR-138-5p on lung adenocarcinoma cells induced by TGF-β remains to be further confirmed. Methods RT-qPCR was used detect expression tissues, adjacent normal and relative cell lines. When A549 H1299 were transfected with negative control (NC), mimics inhibitor lipofectamine3000 treated or without TGF-β1, detected Immunofluorescence, Western blotting (WB), counting Kit-8 (CCK8), colony formation, EdU, Wound-healing Transwell assays. The relation between zinc finger E-box-binding homeobox 2 (ZEB2) RT-qPCR, WB, Luciferase reporter ZEB2 knocked down, CCK8 Results decreased tissues overexpression suppressed EMT, proliferation metastasis H1299. verified direct target miR-138-5p. Downregulation cell, which could reversed inhibitor. Conclusions inhibits epithelial-mesenchymal transition, through targeting ZEB2.

参考文章(41)
Yichun Qiao, Chiou-Nan Shiue, Jian Zhu, Ting Zhuang, Philip Jonsson, Anthony P.H. Wright, Chunyan Zhao, Karin Dahlman-Wright, AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer. Oncotarget. ,vol. 6, pp. 7804- 7814 ,(2015) , 10.18632/ONCOTARGET.3158
Fei Ma, Mingdi Zhang, Wei Gong, Mingzhe Weng, Zhiwei Quan, MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma. PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0126499
Silvia Prislei, Enrica Martinelli, Gian Franco Zannoni, Marco Petrillo, Flavia Filippetti, Marisa Mariani, Simona Mozzetti, Giuseppina Raspaglio, Giovanni Scambia, Cristiano Ferlini, Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer Oncotarget. ,vol. 6, pp. 18966- 18979 ,(2015) , 10.18632/ONCOTARGET.3943
Rik Derynck, Baby Periyanayaki Muthusamy, Koy Y Saeteurn, Signaling pathway cooperation in TGF-β-induced epithelial–mesenchymal transition Current Opinion in Cell Biology. ,vol. 31, pp. 56- 66 ,(2014) , 10.1016/J.CEB.2014.09.001
Shun Fang, Xiangping Zeng, Weiliang Zhu, Ruixiang Tang, Yilan Chao, Linlang Guo, Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer Experimental and Molecular Pathology. ,vol. 96, pp. 438- 444 ,(2014) , 10.1016/J.YEXMP.2014.04.008
Mitsuhiko Osaki, Futoshi Okada, Takahiro Ochiya, miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence Therapeutic Delivery. ,vol. 6, pp. 323- 337 ,(2015) , 10.4155/TDE.14.122
Guodong Xu, Hui Yu, Xinbao Shi, Lebo Sun, Qingyun Zhou, Dawei Zheng, Huoshun Shi, Ni Li, Xianning Zhang, Guofeng Shao, Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 BMC Pulmonary Medicine. ,vol. 14, pp. 174- 174 ,(2014) , 10.1186/1471-2466-14-174
Zhihong Yang, Baocun Sun, Yanlei Li, Xiulan Zhao, Xueming Zhao, Qiang Gu, Jindan An, Xueyi Dong, Fang Liu, Yong Wang, ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma Experimental and Molecular Pathology. ,vol. 98, pp. 352- 359 ,(2015) , 10.1016/J.YEXMP.2015.03.030
Tzu-Hsuan Huang, Fangting Wu, Gabriel B. Loeb, Ruby Hsu, Amy Heidersbach, Allison Brincat, Dai Horiuchi, Robert J. Lebbink, Yin-Yuan Mo, Andrei Goga, Michael T. McManus, Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. Journal of Biological Chemistry. ,vol. 284, pp. 18515- 18524 ,(2009) , 10.1074/JBC.M109.006676
Héctor Peinado, David Olmeda, Amparo Cano, Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nature Reviews Cancer. ,vol. 7, pp. 415- 428 ,(2007) , 10.1038/NRC2131